Quantification of tumor-infiltrating CD8+ T cells expressing Granzyme-B or binding H-2Kb-OVA tetramer revealed that vaccination with necrotic cell-primed MFG-E8 KO DC increased the frequency of OVA-specific CD8+ cytotoxic T lymphocytes in tumor tissues (Figure 6D and Figure S2). Here, CD8A is linked to neoplasm.